NCT02465593 2022-01-11
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
PharmaEngine
Phase 1/2 Terminated
PharmaEngine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
UNC Lineberger Comprehensive Cancer Center
Swiss Cancer Institute
Stanford University
Roswell Park Cancer Institute